Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.| Multiple Sclerosis News Today
Trageting abnormal brain cells linked to chronic inflammation may be key to treating people with progressive forms of MS, a study found.| Multiple Sclerosis News Today
EG110A received FDA fast track designation to treat neurogenic detrusor overactivity, a bladder issue common in MS.| Multiple Sclerosis News Today
Seizures in people with MS may be driven by changes in levels of certain brain signaling molecules, according to a mouse study.| Multiple Sclerosis News Today
After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking and hand function.| Multiple Sclerosis News Today
Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell therapy.| Multiple Sclerosis News Today
For columnist Leigh Anne Nelson, the benefits of owning dogs include a constant source of comfort and motivation to stay active.| Multiple Sclerosis News Today
Bruce Bebo, executive vice president of research at the National MS Society, says NMSS investments are helping advance MS research and care.| Multiple Sclerosis News Today
Using noninvasive eye scans may help clinicians determine if patients have NMOSD or MS, particularly in early disease stages, a study found.| Neuromyelitis News
In a mouse model of Parkinson’s, continuous exposure to low-oxygen air eased or even reversed motor symptoms and slowed disease progression.| Parkinson's News Today
A team of scientists analyzed data from over a dozen studies involving more than 900 people with MS to research iron rim lesions.| Multiple Sclerosis News Today
Transcranial direct current stimulation (tDCS) didn't outperform a sham treatment in easing fatigue in adults with multiple sclerosis.| Multiple Sclerosis News Today
Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says.| Multiple Sclerosis News Today
In MS, slowly expanding lesions were linked to more myelin loss in brain regions of damage and in normal-appearing brain tissue, per a study.| Multiple Sclerosis News Today
Columnist Ben Hofmeister offers insight into his strategy of learning about MS care by using knowledge he already has.| Multiple Sclerosis News Today
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease that causes inflammation of the optic nerve and the spinal cord.| Neuromyelitis News
Living with a chronic illness such as multiple sclerosis (MS) can lead to mental health challenges, such as depression and anxiety.| Multiple Sclerosis News Today
Cognitive impairment has been a challenging symptom of multiple sclerosis for columnist Desiree Lama. Here's how she copes with it.| Multiple Sclerosis News Today
Many people with MS experience heat intolerance. Triggers can include hot weather, increases in body temperature after exercise, or fever.| Multiple Sclerosis News Today
Gilenya (fingolimod) is a disease-modifying therapy for relapsing forms of MS. Learn more about its uses, indications, and side effects.| Multiple Sclerosis News Today
Migraines affect around 24% of people with MS, and are about two times more likely to occur in these patients than in healthy individuals.| Multiple Sclerosis News Today
MRI is an imaging technique that can aid in diagnosing MS. Learn more about how this tool is used to detect MS and assess damage in the CNS.| Multiple Sclerosis News Today
Columnist Leigh Anne Nelson, who's undergone many scans, offers readers her lessons in how to prepare for an MRI.| Multiple Sclerosis News Today
Fampyra (fampridine), which is approved to boost walking ability in adults with MS, may help people with poor working memory, a study says.| Multiple Sclerosis News Today
Columnist Jennifer Powell describes her experience dealing with heat, which tends to worsen her MS symptoms.| Multiple Sclerosis News Today
When it comes to managing MS, what works for me might not work for you, and vice versa, says columnist Ben Hofmeister.| Multiple Sclerosis News Today
In the years since her MS diagnosis, columnist Desiree Lama has learned the importance of accepting help and support from loved ones.| Multiple Sclerosis News Today
Living with NMOSD and its resulting disability can make it hard to find and keep employment, a new U.S. study highlights.| Neuromyelitis News
A family of molecules that can influence immune activity may spot neuromyelitis optica spectrum disorder in people, serving as biomarkers.| Neuromyelitis News
MS is categorized into four main types: CIS, RRMS, SPMS, and PPMS. Learn more about each different type, their presentation, and treatment.| Multiple Sclerosis News Today
Columnist Desiree Lama shares how a diagnosis of MS both halted her from scholastic pursuits and shifted her in a new direction.| Multiple Sclerosis News Today
Support and companionship are just a few benefits of having a cat, says columnist Desiree Lama, who writes about her furry friend, Lucky.| Multiple Sclerosis News Today
In this month's Expert Voices, physical therapist Mandy Rohrig answers readers' questions about exercising with multiple sclerosis.| Multiple Sclerosis News Today
Columnist Susan Payrovi discovers how her body prefers to follow natural circadian rhythms, or biological clocks.| Multiple Sclerosis News Today
In her columns debut, Desiree Lama shares the story of how vision loss and optic neuritis led to her multiple sclerosis diagnosis in 2016.| Multiple Sclerosis News Today
Spending time outdoors helps columnist Susan Payrovi wake up her body systems and manage her multiple sclerosis symptoms.| Multiple Sclerosis News Today
Symptoms and early signs of MS vary from person to person. Common symptoms include movement problems, pain, fatigue, and vision problems.| Multiple Sclerosis News Today
Living with MS to the fullest may mean making positive choices about your physical and mental health: here are some tips.| Multiple Sclerosis News Today
Several tests, including MRI and blood tests, can be used to diagnose MS. Learn more about testing and what to expect after a diagnosis.| Multiple Sclerosis News Today
With 17 piercings, columnist Desiree Lama had to find ways to accommodate annual MRIs, considering all the jewelry she wears.| Multiple Sclerosis News Today
An ALS diagnosis requires testing for signs of the neurodegenerative disease that rules out other disorders with similar symptoms.| ALS News Today
CNM-Au8 is an experimental liquid treatment for people with ALS that intends to increase cell energy.| ALS News Today
Work in a Rett cell model found the potential gold nanocrystal therapy significantly improved mitochondrial function and neuronal health.| Rett Syndrome News
Diagnosing NMOSD typically involves a detailed medical history, a thorough clinical evaluation, and specialized imaging and laboratory tests.| Neuromyelitis News
Taking ginseng tablets twice a day for three months lessened fatigue in people with NMOSD, a placebo-controlled Phase 3 trial found.| Neuromyelitis News
Sex ratio and age at onset among NMOSD patients are influenced by the proportion of cases with anti-AQP4 antibodies, a review study found.| Neuromyelitis News
The exact causes of MS are not known, but several factors, such as genetic factors, infection, and demographics, are linked to MS development.| Multiple Sclerosis News Today
In MS, the myelin sheath is damaged by the immune system's inflammatory attack. Learn more about its function and how it relates to MS.| Multiple Sclerosis News Today
MS is not usually fatal, but it may increase the risk of life-threatening complications. Learn more about MS progression and life expectancy.| Multiple Sclerosis News Today
MS is defined by the presence of lesions in the nervous system. Learn more about MS lesions and view a picture of what brain lesions look like on an MRI.| Multiple Sclerosis News Today
While diet cannot replace treatment, studies suggest that a balanced diet may help patients to better manage and control multiple sclerosis.| Multiple Sclerosis News Today
Columnist Ben Hofmeister says MS is part of who he is, but he maintains the essence of himself without letting MS define him.| Multiple Sclerosis News Today
Iaso Bio has received clearance from the FDA to start clinical trials to test its CAR T-cell therapy equecabtagene autoleucel in MS patients.| Multiple Sclerosis News Today
Most nonactive SPMS patients who took foralumab nasal spray for at least six months saw a decrease in microglial activity in their brains.| Multiple Sclerosis News Today
FibroBiologics has filed an application with the U.S. Patent and Trademark Office covering the use of its technology to treat lupus.| Lupus News Today